T1h (anti-CD6)

2 trials

Sponsors

Center of Molecular Immunology (CIM)

Conditions

Rheumatoid Arthritis

Phase 1

Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients

Active, not recruitingRPCEC00000007

Center of Molecular Immunology (CIM)Rheumatoid Arthritis

Start: 2004-07-30Target: 15Updated: 2026-09-14

Phase 2

Evaluation of Safety and Efficacy of T1h (anti-CD6) as Monotherapy and in Combination with Methotrexate in Patientes with Rheumatoid Arthritis

Active, not recruitingRPCEC00000035

Center of Molecular Immunology (CIM)Rheumatoid Arthritis

Start: 2008-01-14Updated: 2026-09-14